(NNOX) – Business Wire
-
Nanox to Report Fourth Quarter 2022 Financial Results on March 9, 2023
-
Nanox Announces Second Quarter 2022 Financial Results and Provides Business Update
-
Nanox to Report Second Quarter 2022 Financial Results on August 16, 2022
-
Nanox Announces Its First Quarter of 2022 Financial Results and Provides Business Update
-
Nanox to Report First Quarter 2022 Results on May 19, 2022
-
NANO-X IMAGING LTD Files 2021 Annual Report on Form 20-F
-
Nanox Announces FDA Clearance for HealthOST Device, an AI Software Measuring Vertebral Compression Fractures and Low Bone Density, Which are Often Associated with Osteoporosis
-
Nanox Opens South Korean Fabrication Plant to Produce Semiconductor Chips for Novel Digital Nanox.ARC 3D X-ray System
-
Nanox Announces Fourth Quarter 2021 Financial Results and Provides Business Update
-
Nanox to Report Fourth Quarter and Full Year 2021 Results on March 31, 2022
-
Nanox to Present at Two Upcoming Investor Conferences in March 2022
-
Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution
-
USARAD, a Nanox Company, Achieves the Joint Commission Re-Certification
-
Nanox to Host Virtual Tour of Nanox.ARC in a Clinical Setting at the Radiology Society of America Annual Meeting and Announces Investor Webinar
-
Nanox Announces Third Quarter 2021 Financial Results and Provides Business Update
-
Nanox to Introduce New Nanox.ARC Procedures, Highlight Nanox.AI Software Solutions at 2021 Radiology Society of North America Annual Meeting
-
Nanox Completes Merger with Zebra Medical Vision, LTD., Re-brand as Nanox.AI, and Acquisition of MDWEB, LLC., and USARAD Holdings, Inc.
-
Nanox to Report Third Quarter 2021 Results on November 17, 2021
-
Nanox Signs MSaaS Agreement for the Deployment of 350 Nanox Systems in South America
-
Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering
-
Zebra Medical Vision Secures 8th FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering
-
In an up-to $200M Acquisition by Nanox, Zebra Medical Vision Brings Its AI to Reimagine Radiology Globally
-
Nanox Enters into Acquisition via Merger Agreement with Zebra Medical Vision Ltd. and Announces Entry into Binding Letter of Intent with USARAD Holdings Inc.
-
Nanox Signs MSaaS Agreement for the Deployment of 1,000 Nanox Systems in Nigeria
-
Nanox Announces FDA Clearance of 510(k) for Single Source Nanox.ARC Digital X-Ray
-
Deep Pharma Intelligence Names Nanox, TransMedics, Outset, Eargo, and Silkroad as Best Health-Tech Companies to Watch in 2021-2022
-
Notice of Lead Plaintiff Deadline for Shareholders in the Nano-X Imaging Ltd. Class Action Lawsuit
-
Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox.ARC Units in Mexico
-
Nanox Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Nanox Announces Pricing of Upsized Initial Public Offering
Back to NNOX Stock Lookup